A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Condition(s) studied
Investigational drug(s) / intervention(s)
Brenipatide: Administered SC
Placebo: Administered SC
Study summary
This study evaluates the safety and efficacy of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC in delaying the return of major depressive symptoms.
The trial is divided into four periods as follows: a screening period that will last approximately 1 month, a treatment period with a potential post treatment period that combined will last a minimum of 12 months, and the follow up period that will last approximately 2 months.
Eligibility
Primary outcome measure(s)
- Time to Relapse Defined as the Number of Days from Randomization to Date on Which the Participant Meets Any Relapse Criterion of Major Depressive Disorder (MDD) — From Randomization in Double-Blind Adjunctive Treatment to First Relapse For at Least 12 Months
Trial sites (181)
| Facility | City | Region | Status |
|---|---|---|---|
| Accellacare - Moorpark | Moorpark | California | Recruiting |
| ATP Clinical Research | Orange | California | Recruiting |
| Yale University School of Medicine | New Haven | Connecticut | Recruiting |
| Encore Medical Research | Hollywood | Florida | Recruiting |
| K2 Medical Research - Maitland | Maitland | Florida | Recruiting |
| Life Medical Research Group Corp | Miami Gardens | Florida | Recruiting |
| Floridian Clinical Research, LLC | Miami Lakes | Florida | Recruiting |
| CLA Research | Naples | Florida | Recruiting |
| Optimal Research Sites | Orange City | Florida | Recruiting |
| Charter Research - Orlando | Orlando | Florida | Recruiting |
| K2 Medical Research - Tampa | Tampa | Florida | Recruiting |
| CenExel iResearch, LLC | Decatur | Georgia | Recruiting |
| Indiana University Health Neuroscience Center | Indianapolis | Indiana | Recruiting |
| Cedar Valley Medical Specialists | Waterloo | Iowa | Recruiting |
| Pharmasite Research, Inc. | Baltimore | Maryland | Recruiting |
| Adams Clinical Boston | Boston | Massachusetts | Recruiting |
| K2 Medical Research - Foxborough | Foxborough | Massachusetts | Recruiting |
| Adams Clinical Watertown | Watertown | Massachusetts | Recruiting |
| Arcturus Healthcare , PLC, Troy Internal Medicine Research Division | Troy | Michigan | Recruiting |
| Arch Clinical Trials | St Louis | Missouri | Recruiting |
| Vector Clinical Trials | Las Vegas | Nevada | Recruiting |
| Adams Clinical Harlem | New York | New York | Recruiting |
| Summit Headlands | Portland | Oregon | Recruiting |
| Penn Medicine: University of Pennsylvania Health System | Philadelphia | Pennsylvania | Recruiting |
| Suburban Research Associates | West Chester | Pennsylvania | Recruiting |
| Circle Clinical Research | Sioux Falls | South Dakota | Recruiting |
| Adams Clinical Dallas | DeSoto | Texas | Recruiting |
| Re:Cognition Health - Fort Worth | Fort Worth | Texas | Recruiting |
| Consano Clinical Research, LLC | Shavano Park | Texas | Recruiting |
| Alpine Research Organization | Clinton | Utah | Recruiting |
| Re:Cognition Health | Fairfax | Virginia | Recruiting |
| Northwest Clinical Research Center | Bellevue | Washington | Recruiting |
| NeuroCentrix | Carlton | Australia | Recruiting |
| Lyell McEwin Hospital | Elizabeth Vale | Australia | Not Yet Recruiting |
| Barwon Health | Geelong | Australia | Recruiting |
| Multidisciplinary Alfred Psychiatry Research Centre | Melbourne | Australia | Recruiting |
| Paratus Clinical Research - Melbourne | Melbourne | Australia | Recruiting |
| Toowoomba Hospital | Toowoomba | Australia | Recruiting |
| Westmead Hospital | Westmead | Australia | Recruiting |
| Hospital das Clínicas da UFMG | Belo Horizonte | Brazil | Not Yet Recruiting |
+ 141 more sites — see the full list on the official registry below.
More Eli Lilly and Company trials in South Korea
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07412756 on ClinicalTrials.gov ↗ ← All trials in South Korea